533例患者自体软骨细胞植入术后5年翻修手术的发生率、时机与危险因素
基于2010—2020年PearlDiver数据库的病例系列(证据等级4),纳入533例20—59岁初次膝关节自体软骨细胞植入(ACI)患者,5年翻修手术发生率为10.3%,其中63%发生在术后前2年;女性(OR 2.58,95%CI 1.22-5.45,P=0.013)和BMI≥35(OR 2.24,95%CI 1.01-4.94,P=0.047)与翻修风险升高相关,年龄、ECI评分及既往或同期骨力线矫正手术与5年翻修无显著关系(P>0.05)。
要点
- 533例初次ACI患者5年翻修手术发生率为10.3%,63%的翻修发生在术后前2年。
- 女性翻修风险升高(OR 2.58,95%CI 1.22-5.45,P=0.013)。
- BMI≥35翻修风险升高(OR 2.24,95%CI 1.01-4.94,P=0.047)。
核心结论
- 533例ACI患者中10.3%在术后前5年需再次关节软骨手术或转为膝关节置换。
- 翻修手术在术后前2年最多。
- 女性与重度肥胖(BMI≥35)与翻修风险升高相关,年龄、ECI评分及既往或同期骨力线矫正手术则无。
- 作者认为这些发现提示ACI治疗膝关节软骨缺损与5年随访的持久结局相关。
研究设计与样本
- 病例系列,证据等级4。
- 查询2010—2020年PearlDiver数据库,纳入20—59岁因膝关节软骨缺损行初次ACI、且无既往软骨手术或膝关节置换的患者。
- 翻修手术定义为5年内再次行ACI、骨软骨同种异体移植、骨软骨自体移植、单间室膝关节置换或全膝关节置换。
- 采用Kaplan-Meier分析评估翻修手术的发生率与时机。
主要发现
- 共533例患者接受初次ACI并符合纳入标准。
- 5年翻修手术发生率为10.3%,63%的翻修发生在术后前2年。
- 女性与翻修手术相关(OR 2.58,95%CI 1.22-5.45,P=0.013)。
- BMI≥35与翻修手术相关(OR 2.24,95%CI 1.01-4.94,P=0.047)。
- 年龄、ECI评分及既往或同期骨力线矫正手术与5年翻修手术无显著关系(P>0.05)。
关键数值与推荐
- 翻修手术定义为5年内再次ACI、骨软骨同种异体移植、骨软骨自体移植、单间室膝关节置换或全膝关节置换。
- 5年翻修手术发生率为10.3%。
- 女性OR 2.58(95%CI 1.22-5.45,P=0.013)。
- BMI≥35的OR 2.24(95%CI 1.01-4.94,P=0.047)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Autologous chondrocyte implantation (ACI) can be used to treat focal, full-thickness chondral defects of the knee. However, there is limited large-sample evidence available regarding the incidence, timing, and risk factors for revision surgery after ACI. PURPOSE: To assess the 5-year incidence, timing, and risk factors for revision surgery after ACI in a large national cohort. STUDY DESIGN: Case series; Level of evidence, 4. METHODS: The 2010-2020 PearlDiver database was queried for patients aged 20 to 59 years who underwent primary ACI of the knee without previous chondral procedures or knee arthroplasty. Revision surgery was defined as subsequent revision ACI, osteochondral allograft transplantation, osteochondral autograft transfer, unicompartmental knee arthroplasty, or total knee arthroplasty within 5 years. Kaplan-Meier analysis was used to assess both incidence and timing of revision surgery. Risk factors evaluated for revision surgery included patient age, sex, body mass index (BMI), Elixhauser Comorbidity Index (ECI) score, and previous or concomitant bony realignment procedures. RESULTS: In total, 533 patients underwent primary ACI and met inclusion criteria. The 5-year incidence of revision surgery was 10.3%, with 63% of revisions occurring in the first 2 years after surgery. Risk factors associated with revision surgery included female sex (odds ratio, 2.58; 95% CI, 1.22-5.45; P = .013) and BMI ≥35 (odds ratio, 2.24; 95% CI, 1.01-4.94; P = .047). There was no relationship between age, ECI score, or previous or concomitant bony realignment procedures and revision surgery at 5 years (P > .05). CONCLUSION: In an analysis of 533 patients who underwent ACI, 10.3% required a subsequent articular cartilage procedure or conversion to knee arthroplasty in the first 5 postoperative years. Revision surgery was greatest in the first 2 postoperative years. Female sex and severe obesity (BMI, ≥35) were associated with increased risk of revision surgery, while age, ECI score, and previous or concomitant bony realignment procedures were not. These findings suggest that treatment of chondral defects of the knee with ACI is associated with durable outcomes at the 5-year follow-up.
引用
- Gillinov SM, Fosam A, Burroughs PJ, et al. Incidence, Timing, and Risk Factors for 5-Year Revision Surgery After Autologous Chondrocyte Implantation in 533 Patients. Am J Sports Med. 2022. PMID: 35916771. doi:10.1177/03635465221111115
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。